Trade Merck KGaA - EUR - MRKd CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.40 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017263% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004959% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 119.55 |
| Open | 121.5 |
| 1-Year Change | -20.09% |
| Day's Range | 120.15 - 122.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 119.55 | 0.15 | 0.13% | 119.40 | 120.25 | 117.85 |
| Apr 23, 2025 | 120.55 | 2.10 | 1.77% | 118.45 | 122.05 | 116.55 |
| Apr 22, 2025 | 117.50 | 0.55 | 0.47% | 116.95 | 117.65 | 114.90 |
| Apr 17, 2025 | 116.35 | -1.25 | -1.06% | 117.60 | 117.85 | 114.70 |
| Apr 16, 2025 | 117.95 | -0.30 | -0.25% | 118.25 | 120.05 | 115.45 |
| Apr 15, 2025 | 118.25 | 0.60 | 0.51% | 117.65 | 118.50 | 117.05 |
| Apr 14, 2025 | 117.50 | 1.05 | 0.90% | 116.45 | 118.00 | 116.45 |
| Apr 11, 2025 | 115.00 | 1.95 | 1.72% | 113.05 | 115.40 | 112.05 |
| Apr 10, 2025 | 112.35 | -3.65 | -3.15% | 116.00 | 118.75 | 112.25 |
| Apr 9, 2025 | 110.75 | -0.10 | -0.09% | 110.85 | 113.15 | 110.35 |
| Apr 8, 2025 | 114.60 | 2.85 | 2.55% | 111.75 | 116.95 | 111.75 |
| Apr 7, 2025 | 113.75 | 2.95 | 2.66% | 110.80 | 118.95 | 110.20 |
| Apr 4, 2025 | 117.35 | -3.55 | -2.94% | 120.90 | 122.45 | 116.25 |
| Apr 3, 2025 | 121.60 | -2.25 | -1.82% | 123.85 | 126.45 | 121.35 |
| Apr 2, 2025 | 125.45 | 0.15 | 0.12% | 125.30 | 125.65 | 122.95 |
| Apr 1, 2025 | 127.10 | -0.45 | -0.35% | 127.55 | 128.75 | 126.30 |
| Mar 31, 2025 | 126.55 | -2.25 | -1.75% | 128.80 | 129.10 | 126.15 |
| Mar 28, 2025 | 130.40 | 2.40 | 1.88% | 128.00 | 131.10 | 128.00 |
| Mar 27, 2025 | 129.35 | 3.75 | 2.99% | 125.60 | 129.35 | 125.60 |
| Mar 26, 2025 | 127.00 | -3.45 | -2.64% | 130.45 | 131.20 | 126.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - EUR Company profile
About Merck KGaA
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.
Equity composition
2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).
| Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com